Nuclear translocation of MRP1 contributes to multidrug resistance of mucoepidermoid carcinoma

Oral Oncology

Volumn 47, Issue 12, 2011, Pages 1134-1140

  Cai, Bo Lei ^a   Xu, Xiao Fang ^a   Fu, Shan Min ^a   Shen, Liang Liang ^a   Zhang, Jing ^a   Guan, Su Min ^a   Wu, Jun Zheng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Mucoepidermoid carcinoma; Multidrug resistance related protein 1; Multidrug resistance; Nuclear translocation; RNA interference

Indexed keywords

BLEOMYCIN A5; CISPLATIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL;

ADENOSQUAMOUS CARCINOMA; ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SALIVARY GLAND; WESTERN BLOTTING;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; BLEOMYCIN; BLOTTING, WESTERN; CARCINOMA, MUCOEPIDERMOID; CELL LINE, TUMOR; CISPLATIN; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; EPIRUBICIN; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FLUOROURACIL; HUMANS; P-GLYCOPROTEIN; PACLITAXEL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALIVARY GLAND NEOPLASMS;

EID: 82255191695     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2011.08.005     Document Type: Article

References (30)

1. M.A. Lopes, L.P. Kowalski, C.S.G. Da, and D.A.O. Paes A clinicopathologic study of 196 intraoral minor salivary gland tumours J Oral Pathol Med 28 6 1999 264 267 (Pubitemid 29298250)
2. C.A. Waldron, S.K. El-Mofty, and D.R. Gnepp Tumors of the intraoral minor salivary glands: a demographic and histologic study of 426 cases Oral Surg Oral Med Oral Pathol 66 3 1988 323 333
3. Y. Wen, X. Dai, C. Wang, L. Li, F. Fu, and X. Wang A retrospective clinical study of 6539 cases of malignant oral-maxillofacial tumors Hua Xi Kou Qiang Yi Xue Za Zhi 19 5 2001 296 299
4. R.B. Bell, E.J. Dierks, L. Homer, and B.E. Potter Management and outcome of patients with malignant salivary gland tumors J Oral Maxillofac Surg 63 7 2005 917 928 (Pubitemid 40897743)
5. E. Vattemi, C. Graiff, T. Sava, R. Pedersini, A. Caldara, and M. Mandara Systemic therapies for recurrent and/or metastatic salivary gland cancers Expert Rev Anticancer Ther 8 3 2008 393 402 (Pubitemid 351836287)
6. W.T. Beck The cell biology of multiple drug resistance Biochem Pharmacol 36 18 1987 2879 2887 (Pubitemid 17142295)
7. M. Lehnert Clinical multidrug resistance in cancer: a multifactorial problem Eur J Cancer 32A 6 1996 912 920
8. G. Szakacs, J.K. Paterson, J.A. Ludwig, C. Booth-Genthe, and M.M. Gottesman Targeting multidrug resistance in cancer Nat Rev Drug Discov 5 3 2006 219 234 (Pubitemid 43336035)
9. L.M. Shlapatska, G.G. Berdova, L.M. Kovalevska, G.I. Kulyk, G. Klein, and S.P. Sidorenko Signal transduction pathways in Burkitt's lymphoma cell lines BL41 and DG75 with different sensitivity to doxorubicin Exp Oncol 26 3 2004 210 216
10. G. Damia, and M. D'Incalci Targeting DNA repair as a promising approach in cancer therapy Eur J Cancer 43 12 2007 1791 1801 (Pubitemid 47238245)
11. P. Karran Mechanisms of tolerance to DNA damaging therapeutic drugs Carcinogenesis 22 12 2001 1931 1937 (Pubitemid 34065386)
12. Y. Pommier, O. Sordet, S. Antony, R.L. Hayward, and K.W. Kohn Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks Oncogene 23 16 2004 2934 2949 (Pubitemid 38638854)
13. M.M. Gottesman Mechanisms of cancer drug resistance Annu Rev Med 53 2002 615 627 (Pubitemid 34177898)
14. J.G. Turner, and D.M. Sullivan CRM1-mediated nuclear export of proteins and drug resistance in cancer Curr Med Chem 15 26 2008 2648 2655
15. Y. Huang, and W. Sadee Membrane transporters and channels in chemoresistance and -sensitivity of tumor cells Cancer Lett 239 2 2006 168 182 (Pubitemid 43996825)
16. M.M. Gottesman, and V. Ling The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research FEBS Lett 580 4 2006 998 1009 (Pubitemid 43185280)
17. S.P. Cole, G. Bhardwaj, J.H. Gerlach, J.E. Mackie, C.E. Grant, and K.C. Almquist Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line Science 258 5088 1992 1650 1654 (Pubitemid 23012438)
18. E.M. Leslie, R.G. Deeley, and S.P. Cole Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense Toxicol Appl Pharmacol 204 3 2005 216 237 (Pubitemid 40552845)
19. J. Bart, H. Hollema, H.J. Groen, E.G. de Vries, N.H. Hendrikse, and D.T. Sleijfer The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours Eur J Cancer 40 14 2004 2064 2070 (Pubitemid 39165539)
20. R.G. Deeley, C. Westlake, and S.P. Cole Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins Physiol Rev 86 3 2006 849 899 (Pubitemid 44033384)
21. M.J. Van Luyn, M. Muller, J. Renes, C. Meijer, R.J. Scheper, and E.F. Nienhuis Transport of glutathione conjugates into secretory vesicles is mediated by the multidrug-resistance protein 1 Int J Cancer 76 1 1998 55 62 (Pubitemid 28164569)
22. Z.S. Chen, T. Furukawa, T. Sumizawa, K. Ono, K. Ueda, and K. Seto ATP-Dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P Mol Pharmacol 55 5 1999 921 928 (Pubitemid 29214612)
23. A. Haimeur, G. Conseil, R.G. Deeley, and S.P. Cole The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation Curr Drug Metab 5 1 2004 21 53 (Pubitemid 38294344)
24. Z. Benderra, A. Trussardi, H. Morjani, A.M. Villa, S.M. Doglia, and M. Manfait Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein Eur J Cancer 36 3 2000 428 434 (Pubitemid 30116741)
25. D.S. Wen, X.L. Zhu, S.M. Guan, Y.M. Wu, L.L. Yu, and J.Z. Wu Silencing of CXCR4 inhibits the proliferation, adhesion, chemotaxis and invasion of salivary gland mucoepidermoid carcinoma Mc3 cells in vitro Oral Oncol 44 6 2008 545 554
26. G.J. Zaman, M.J. Flens, M.R. van Leusden, M. de Haas, H.S. Mulder, and J. Lankelma The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump Proc Natl Acad Sci USA 91 19 1994 8822 8826
27. M.J. Flens, M.A. Izquierdo, G.L. Scheffer, J.M. Fritz, C.J. Meijer, and R.J. Scheper Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies Cancer Res 54 17 1994 4557 4563 (Pubitemid 24276470)
28. M.J. Flens, G.J. Zaman, P. van der Valk, M.A. Izquierdo, A.B. Schroeijers, and G.L. Scheffer Tissue distribution of the multidrug resistance protein Am J Pathol 148 4 1996 1237 1247 (Pubitemid 26111082)
29. S.H. Cheng, W. Lam, A.S. Lee, K.P. Fung, R.S. Wu, and W.F. Fong Low-level doxorubicin resistance in benzo[a]pyrene-treated KB-3-1 cells is associated with increased LRP expression and altered subcellular drug distribution Toxicol Appl Pharmacol 164 2 2000 134 142 (Pubitemid 30238532)
30. Y. Cui, J. Konig, J.K. Buchholz, H. Spring, I. Leier, and D. Keppler Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells Mol Pharmacol 55 5 1999 929 937 (Pubitemid 29214613)